• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

10 New Drugs for Primary Care: Q4 2018

Slideshow

From acne to the menacing flu, we have picked the top 10 FDA-approved drugs every primary care physician should know about from the fourth quarter. 

While a new year is already underway, let’s take a quick look back at fourth quarter 2018 and round out the year’s FDA approvals for drugs that treat conditions often seen in primary care. Scroll through the slideshow below to find details on the first new drug to treat influenza in 20 years; the first over-the-counter inhaler approved in the US; a digital inhaler with built-in sensors that connects to a mobile app; plus 7 more.

New FDA-approved drugs, fourth quarter drugs, primary care

For a quick review of primary care drugs approved in the first quarter of 2018, please go to 9 New Drugs for Primary Care: Q1 2018

For a quick review of primary care drugs approved in the second quarter of 2018, please go to 10 New Drugs for Primary Care: Q2 2018

For a quick review of primary care drugs approved in the third quarter of 2018, please go to 9 New Drugs for Primary Care: Q3 2018

Related Content
© 2025 MJH Life Sciences

All rights reserved.